Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Heinemann

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Contraception|January 20, 2000
Is the stroke risk in OC users higher in Europe than in North America?L A Heinemann, L A Heinemann
Contraception|December 5, 2000
Emerging evidence on oral contraceptives and arterial diseaseL A Heinemann
Human Reproduction Update|February 1, 2000
The changing scene--an unnecessary pill crisisL A Heinemann
Deutsche Medizinische Wochenschrift (1946)|August 23, 1996
[Do 3rd-generation ovulation inhibitors have a new risk profile?]L A Heinemann
British Journal of Haematology|August 1, 1997
Oral contraceptives and venous thromboembolism: acquired APC resistance?W Schramm, L A Heinemann
Lancet (London, England)|May 31, 1997
Oral contraceptives and venous thromboembolismM A Lewis, L A Heinemann
Zentralblatt Fur Gynakologie|September 6, 2001
[Reasons for the change in HRT therapy from the perspective of women. Results of the German Cohort Study on Women's Health]C Thiel, L A Heinemann, A Assmann, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 16, 2000
Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?M Spannagl, L A Heinemann, W Schramm
Pharmacoepidemiology and Drug Safety|May 1, 1996
Multicentre international liver tumour study protocol of the case-control study on hepatocellular cancerL A Heinemann, D B Thomas, M Möhner, et al.
American Journal of Obstetrics and Gynecology|June 3, 1998
Scientific problems with a noncausal artifactL A Heinemann, W O Spitzer, U H Winkler
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Contraception|January 20, 2000
Is the stroke risk in OC users higher in Europe than in North America?L A Heinemann, L A Heinemann
Contraception|December 5, 2000
Emerging evidence on oral contraceptives and arterial diseaseL A Heinemann
Human Reproduction Update|February 1, 2000
The changing scene--an unnecessary pill crisisL A Heinemann
Deutsche Medizinische Wochenschrift (1946)|August 23, 1996
[Do 3rd-generation ovulation inhibitors have a new risk profile?]L A Heinemann
British Journal of Haematology|August 1, 1997
Oral contraceptives and venous thromboembolism: acquired APC resistance?W Schramm, L A Heinemann
Lancet (London, England)|May 31, 1997
Oral contraceptives and venous thromboembolismM A Lewis, L A Heinemann
Zentralblatt Fur Gynakologie|September 6, 2001
[Reasons for the change in HRT therapy from the perspective of women. Results of the German Cohort Study on Women's Health]C Thiel, L A Heinemann, A Assmann, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|August 16, 2000
Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?M Spannagl, L A Heinemann, W Schramm
Pharmacoepidemiology and Drug Safety|May 1, 1996
Multicentre international liver tumour study protocol of the case-control study on hepatocellular cancerL A Heinemann, D B Thomas, M Möhner, et al.
American Journal of Obstetrics and Gynecology|June 3, 1998
Scientific problems with a noncausal artifactL A Heinemann, W O Spitzer, U H Winkler
Pageof 5